Our target market consists of parents, caregivers, and physicians of pediatric patients with neurological disorders or injuries. This reaches the demographic population which consists of approximately 200,000 patients and contributes to the market share of an estimated $2.8 million.

Other methods of helping patients with mobility issues may come with complications of accessibility, safety issues, and cost effectiveness. Pediatric patients may not have the availability to attend physical therapy multiple times a week and devices that induce electromyostimulation offer risks in terms of tissue damage, organ damage, and skin irritation. In addition, buying products such as those may cost patients upwards to $500.